Lithuanian fighter S. Maslobojev has been handed a 12-month suspension by the Glory organization after a doping violation was confirmed, revealing the presence of stanozolol metabolite in a sample collected on June 14, 2025. The announcement was made officially by Glory on Wednesday, highlighting the seriousness of the situation for the 38-year-old athlete. In response to this disqualification, Maslobojev released a public statement detailing his dedication to clean sport and his long-standing compliance with anti-doping regulations throughout his career.

In his statement, Maslobojev expressed respect for the objectives of the anti-doping system, clarifying that he has always fought for integrity in sports and has been consistently tested under WADA protocols since 2012. He insisted he has never sought an unfair advantage and, upon learning about the doping findings in his sample, he took immediate action to clarify the facts surrounding the case. This included conducting independent investigations at AlphaBiolabs in London, a laboratory certified under ISO 17025 standards, which underlines the credibility of the tests performed.

This incident raises critical questions about the challenges athletes face regarding doping violations and the impact of such situations on their careers. The implications for Maslobojev could be significant, affecting not only his immediate future in the sport but also his reputation and the trust he has built with fans and fellow athletes. As investigations continue, the case may contribute to broader discussions about doping in combat sports and the measures necessary to ensure fairness and safety in competitive environments.